n-3 Fatty acids and lipid peroxidation in breast cancer inhibition
- 9 March 2002
- journal article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 87 (3), 193-198
- https://doi.org/10.1079/bjn2001512
Abstract
Long-chain n-3 fatty acids (FA) consistently inhibit the growth of human breast cancer (BC) cells both in culture and in grafts in immunosuppressed mice. Large cohort studies have, however, failed to confirm a protective effect for fish oils rich in n-3 FA against BC risk. The present review examines new evidence on biological mechanisms which may be involved in the inhibition of mammary carcinogenesis by long-chain n-3 FA, focusing on an apoptotic effect by its lipid peroxidation products. Dietary intake of n-3 FA leads to their incorporation into cell membrane lipids. Increased apoptosis in human BC cells following exposure to long-chain n-3 FA such as eicosapentaenoic and docosahexaenoic acids is generally ascribed to their inhibition of cyclooxygenase 2 which promotes mammary carcinogenesis. In addition however, long-chain n-3 FA are particularly likely to activate peroxisome proliferator-activated receptor (PPAR)-γ, a key regulator of lipid metabolism but also capable of modulating proliferative activity in a variety of cells including mammary cells. Expression of PPAR-γ in the nucleus is activated by second messengers such as J series prostaglandins and the latter have been shown to cause apoptosis in vivo in explants of human BC cells in immunosuppressed mice. In mammary tumours, it is observed that long-chain FA not only increase apoptosis, but also increase lipid peroxidation, and the apoptotic effect can be reversed by antioxidants. The rationale for use of n-3 FA dietary supplements in counteracting BC progression needs to be tested clinically in a phase 2 pilot study, while at the same time, the effect on whole-body lipid peroxidation needs to be monitored. Dietary supplements of fish oil rich in n-3 FA are proposed for premenopausal women over the age of 40 years who are shown to be at increased BC risk. Biological markers in breast tissue of BC progression will be monitored, and observed changes related to serial plasma levels of isoprostanes as a measure of whole-body lipid peroxidation.Keywords
This publication has 56 references indexed in Scilit:
- Peroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial CellsPublished by Elsevier BV ,1999
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Vitamin E and breast cancer: A reviewNutrition and Cancer, 1997
- Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissueEuropean Journal of Cancer, 1996
- Review of the effects of dietary fat on experimental mammary gland tumorigenesis: Role of lipid peroxidationFree Radical Biology & Medicine, 1995
- The Role of Fatty Acids and Eicosanoid Synthesis Inhibitors in Breast CarcinomaOncology, 1995
- Consumption of Meat, Animal Products, Protein, and Fat and Risk of Breast CancerEpidemiology, 1994
- n-3 pufa and α-tocopherol control of tumor cell proliferationMolecular Aspects of Medicine, 1993
- Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 norwegian womenInternational Journal of Cancer, 1990
- Fish consumption and breast cancer risk: An ecological studyNutrition and Cancer, 1989